Size and Concentration of Cell-Free DNA Measured Directly from Blood Plasma, without Prior DNA Extraction

ABSTRACT: Cell-free DNA in human blood plasma (cfDNA) is now widely used and studied as a biomarker for several physiological and pathological situations. In addition to genetic and epigenetic alterations that provide information about the presence and the nature of non-constitutive DNA in the body, cfDNA concentration and size distribution may potentially be independent biomarkers … Continue reading

August 18, 2023

Communiqué de presse (TTT) :

Essor de la technologie d’analyse génétique µLAS (Biabooster), utilisée dans le cadre d’une étude clinique dirigée par les Hôpitaux Universitaires de Marseille   Les Hôpitaux de Marseille mènent une étude clinique visant à prédire précocement la réponse aux immunothérapies chez les patients atteints de différents types de cancer. La technologie µLAS est une méthode simple … Continue reading

June 15, 2023

Characterization of plasma cell-free DNA integrity using BIABooster system

[…] Recently, using a novel technology (BIABooster system) based on electro-hydrodynamic actuation, we also suggested the pertinence of total ccfDNA quantification and size profiling for several cancers including melanoma, CRC, non-small cell lung cancer (NSCLC) and prostate cancer […]. READ the original research article: Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward … Continue reading

June 9, 2021